CureVac appoints Pierre Kemula as chief financial officer
Mr. Kemula will join CureVac’s management board.
Mr. Kemula joins CureVac after serving as Chief Financial Officer of Pixium Vision, a medical technology company developing innovative Bionic Vision Systems to provide a form of vision to blind patients suffering from outer retinal degeneration.
During his tenure as CFO of Pixium Vision, Mr. Kemula was instrumental in the company’s successful initial public offering on Euronext.
Prior to Pixium Vision, Mr. Kemula was with Ipsen, a global specialty-driven pharmaceutical company, where he held the position of Vice President Corporate Finance, Treasury and Financial Markets.
Mr. Kemula began his career in consulting, with successful tenures at Roland Berger, Kea & Partners, Gemini Consulting and KPMG.
He received his degree in Management Sciences from the London School of Economics (LSE) in the United Kingdom.